A Phase III Study of Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Diseases and Conditions Researched

Other Hematopoietic

What is the purpose of this trial?

This randomized phase III trial studies chlorhexidine gluconate cleansing to see how well it works compared to control cleansing in preventing central line associated bloodstream infection and acquisition of multi-drug resistant organisms in younger patients with cancer or undergoing donor stem cell transplant. Chlorhexidine gluconate may help reduce bloodstream infections and bacterial infections associated with the central line.

Participation Guidelines

Age: Any

Click here for detailed participation information for this trial.

Sponsor: Children's Oncology Group (The)
Last Updated:
Study HIC#: 1401013314